We are live on ! Find out more
ORKA

Oruka Therapeutics
ORKA

14 hedge funds and large institutions have $2.68M invested in Oruka Therapeutics in 2013 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 1

207% more capital invested

Capital invested by funds: $873K → $2.68M (+$1.8M)

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

40% more funds holding

Funds holding: 10 → 14 (+4)

Holders
14
Holders Change
+4
Holders Change %
+40%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
6
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$796K
2
Deutsche Bank
Deutsche Bank
Germany
+$415K
3
BCM
Bridgeway Capital Management
Texas
+$182K
4
DS
DRW Securities
Illinois
+$152K
5
Morgan Stanley
Morgan Stanley
New York
+$85.4K

Top Sellers

Rank Fund Capital Flow
1
BIT
BlackRock Institutional Trust
California
-$115K
2
Nomura Holdings
Nomura Holdings
Japan
-$43.8K
3
SGH
Schonfeld Group Holdings
New York
-$16K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$1.03M +$796K +345 +556%
Deutsche Bank
2
Deutsche Bank
Germany
$589K +$415K +180 +346%
Vanguard Group
3
Vanguard Group
Pennsylvania
$292K +$18.5K +8 +7%
BCM
4
Bridgeway Capital Management
Texas
$202K +$182K +79 New
DS
5
DRW Securities
Illinois
$168K +$152K +66 New
Bank of America
6
Bank of America
North Carolina
$119K +$2.31K +1 +2%
Morgan Stanley
7
Morgan Stanley
New York
$95K +$85.4K +37 New
HighTower Advisors
8
HighTower Advisors
Illinois
$72K +$23.1K +10 +56%
Northern Trust
9
Northern Trust
Illinois
$53K +$48.5K +21 New
TRCT
10
Tower Research Capital (TRC)
New York
$25K +$23.1K +10 New
FNYS
11
First New York Securities
New York
$14K +$11.5K +5 New
BA
12
BlackRock Advisors
Delaware
$9K +$4.62K +2 +100%
California Public Employees Retirement System
13
California Public Employees Retirement System
California
$3K – – –
Nomura Holdings
14
Nomura Holdings
Japan
$2K -$43.8K -19 -95%
BIT
15
BlackRock Institutional Trust
California
– -$115K -48 Closed
SGH
16
Schonfeld Group Holdings
New York
– -$16K -7 Closed

ORKA Hedge Fund Activity: Q4 2013 in Review

14 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Oruka Therapeutics (ORKA) for Q4 2013, worth a combined $2.68M — up 207% from $873K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new ORKA positions and 2 closed out — a net gain of 4 holders — while 6 added to existing stakes and 1 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $796K. The largest seller was BlackRock Institutional Trust, exiting entirely with an estimated $115K sold.

  • 14 institutional investors held Oruka Therapeutics (ORKA) as of Q4 2013, up from 10 in Q3 2013.
  • Funds reported $2.68M of Oruka Therapeutics stock for Q4 2013, up 207% quarter-over-quarter.
  • 6 funds opened new Oruka Therapeutics positions in Q4 2013 and 2 closed out, a net change of +4 holders.
  • The largest Oruka Therapeutics buyer in Q4 2013 was Renaissance Technologies, an estimated $796K added.
  • The largest Oruka Therapeutics seller in Q4 2013 was BlackRock Institutional Trust, an estimated $115K sold.

Based on aggregated 13F filings for Q4 2013.